Anti-HLA antibodies in heart transplantation

被引：46

作者：

Vasilescu, ER

Ho, EK

de la Torre, L

Itescu, S

Marboe, C

Cortesini, R

Suciu-Foca, N

Mancini, D

机构：

[1] Columbia Univ, Dept Pathol, New York, NY 10032 USA

[2] Columbia Univ, Dept Internal Med, New York, NY 10032 USA

来源：

TRANSPLANT IMMUNOLOGY | 2004年 / 12卷 / 02期

关键词：

HLA antibodies; heart transplantation; transplant-related coronary artery disease;

D O I：

10.1016/j.trim.2003.08.002

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We have analyzed the relationship between the development of transplant-related coronary artery disease (TRCAD) and the following potential risk factors: (a) number of HLA mismatches between recipient and donor; (b) production of anti-HLA antibodies; (c) growth of lymphocytes infiltrating the graft; and (d) frequency of biopsy proven episodes of acute rejection. The study population consisted of 285 adult heart allograft recipients who were monitored over a period of two years or more. The results demonstrate a significant correlation between TRCAD, generation of anti-HLA class II antibodies and potential of lymphocytes infiltrating the graft to proliferate ex-vivo in medium containing IL-2. Humoral and cellular immune responses to HLA-DR antigens expressed by the graft seem to underlie the development of TRCAD. (C) 2003 Elsevier B.V. All rights reserved.

引用

页码：177 / 183

页数：7

共 54 条

[41] OUTCOME OF CARDIAC TRANSPLANT RECIPIENTS WITH A POSITIVE DONOR-SPECIFIC CROSS-MATCH - PRELIMINARY-RESULTS WITH PLASMAPHERESIS [J].

RATKOVEC, RM ;

HAMMOND, EH ;

OCONNELL, JB ;

BRISTOW, MR ;

DEWITT, CW ;

RICHENBACHER, WE ;

MILLAR, RC ;

RENLUND, DG .

TRANSPLANTATION, 1992, 54 (04) :651-655

[42]

ROSE EA, 1992, J HEART LUNG TRANSPL, V11, pS120

[43]

ROSE EA, 1989, SURGERY, V106, P203

[44] SPECIFICITY OF LYMPHOCYTOTOXIC ANTIBODIES FORMED AFTER CARDIAC TRANSPLANTATION AND CORRELATION WITH REJECTION EPISODES [J].

SMITH, JD ;

DANSKINE, AJ ;

ROSE, ML ;

YACOUB, MH .

TRANSPLANTATION, 1992, 53 (06) :1358-1362

[45]

Smith T., 1893, USDA BUREAU ANIMAL I, V1, P1

[46]

SUCIUFOCA N, 1974, LAB INVEST, V31, P1

[47]

SUCIUFOCA N, 1978, TRANSPLANT P, V10, P493

[48] SOLUBLE HLA ANTIGENS, ANTI-HLA ANTIBODIES, AND ANTIIDIOTYPIC ANTIBODIES IN THE CIRCULATION OF RENAL-TRANSPLANT RECIPIENTS [J].

SUCIUFOCA, N ;

REED, E ;

DAGATI, VD ;

HO, E ;

COHEN, DJ ;

BENVENISTY, AI ;

MCCABE, R ;

BRENSILVER, JM ;

KING, DW ;

HARDY, MA .

TRANSPLANTATION, 1991, 51 (03) :593-601

[49] THE ROLE OF ANTI-HLA ANTIBODIES IN HEART-TRANSPLANTATION [J].

SUCIUFOCA, N ;

REED, E ;

MARBOE, C ;

HARRIS, P ;

YU, PX ;

SUN, YK ;

HO, E ;

ROSE, E ;

REEMTSMA, K ;

KING, DW .

TRANSPLANTATION, 1991, 51 (03) :716-724

[50] Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection [J].

Tambur, AR ;

Bray, RA ;

Takemoto, SK ;

Mancini, M ;

Costanzo, MR ;

Kobashigawa, JA ;

D'Amico, CL ;

Kanter, KR ;

Berg, A ;

Vega, JD ;

Smith, AL ;

Roggero, AL ;

Ortegel, JW ;

Wilmoth-Hosey, L ;

Cecka, JM ;

Gebel, HM .

TRANSPLANTATION, 2000, 70 (07) :1055-1059

← 1 2 3 4 5 6 →